id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2011-D-0611-0080,FDA,FDA-2011-D-0611,Memorandum of Meeting to Discuss Post-Licensure Biosimilar Labeling Changes,Other,Memorandum,2019-07-18T04:00:00Z,2019,7,2019-07-18T04:00:00Z,,2019-07-18T15:21:39Z,,0,0,0900006483d9d811